HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

10-carboxymethyl-9-acridanone

Subscribe to New Research on 10-carboxymethyl-9-acridanone

RN given refers to parent cpd

Also Known As:

10(9H)-acridineacetic acid, 9-oxo-; 10-carboxymethyl-9-acridanone, sodium salt; 9-oxo-10-acridineacetic acid; acridone N-methyl-N-(alpha,D-glucopyranosyl)ammonium 10-methylenecarboxylate; cycloferon

Networked: 110 relevant articles (37 outcomes, 12 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 60
- 3-Ring Heterocyclic Compounds
  - Acridines: 28
    - 10-carboxymethyl-9-acridanone: 110

Experts

1.	Romantsov, M G: 30 articles (01/2014 - 11/2004)
2.	Kovalenko, A L: 27 articles (01/2014 - 01/2000)
3.	Shul'diakov, A A: 17 articles (01/2014 - 01/2009)
4.	Sologub, T V: 10 articles (01/2012 - 01/2009)
5.	Sukhanov, D S: 9 articles (01/2014 - 11/2009)
6.	Ershov, F I: 8 articles (01/2014 - 01/2000)
7.	Frolov, V M: 7 articles (03/2013 - 01/2011)
8.	Soboleva, L A: 6 articles (01/2015 - 01/2010)
9.	Kruglova, O V: 5 articles (03/2013 - 01/2012)
10.	Isakov, V A: 4 articles (01/2015 - 01/2009)

Related Diseases

1.	Infection 01/01/2012 - "The use of cycloferon in two courses with a 2-week interval according to the standard scheme is recommended for prophylaxis of acute respiratory diseases in the group of children with frequent and prolonged diseases during epidemiologically unfavourable periods and for complex therapy of rhinopharinx infections as an agent increasing efficacy of other antibacterials." 01/01/2014 - "[Cycloferon and management of herpes virus infection]." 01/01/2013 - "Complex clinical and laboratory examination of patients with HCV infection revealed that the use of cycloferon provided earlier normalization of the clinical and biochemical parameters and lower immunological imbalance vs. the basic therapy alone. " 01/01/2013 - "[Efficiency of cycloferon against slow viral infection caused by SV-40 in monkeys and man]." 01/01/2012 - "The administration of cycloferon significantly increases the absorptive and digestive activity of phagocytosis by peritoneal macrophages, which has been inhibited during the development of experimental MBT infection."
2.	Human Influenza (Influenza) 09/01/2000 - "Protective effect of granulated cycloferon has been studied in albino mice infected with influenza. " 09/01/2000 - "[Protective effect of cycloferon in experimental influenza]." 01/01/2012 - "The epidemiologic efficacy of cycloferon, as an agent of nonspecific immunoprophylaxis for FIC during seasonal prevalence of respiratory tract infection and influenza cases was shown." 01/01/2015 - "[THE USE OF CYCLOFERON FOR THE TREATMENT AND PREVENTION OF INFLUENZA AND ACUTE RESPIRATORY VIRAL INFECTIONS]." 01/01/2011 - "The administration of cycloferon results in stimulation of the immune response, restriction of the foci of post-influenza pneumonia, and normalization of the structure of respiratory zones independently of the susceptibility or resistance of infectious virus to the drugs. "
3.	Brucellosis (Malta Fever) 01/01/2010 - "[Efficacy of cycloferon in the treatment of brucellosis]." 09/01/2012 - "[Effectiveness of cycloferon in complex treatment of brucellosis patients with lesions of the scrotum]." 01/01/2011 - "Indices of the quality of life and parameters of the psychofunctional status of patients with chronic active brucellosis are presented and the clinical efficiency of immunomodulator cycloferon in a complex therapy of this disease is estimated for a group of 40 patients. " 01/01/2010 - "[Cycloferon in complex therapy of chronic brucellosis]." 01/01/2011 - "[Effect of immunomodulator cycloferon on quality of life and psychoemotional state of patients with chronic active brucellosis subjected to complex pharmacotherapy]."
4.	Pulmonary Tuberculosis 01/01/2013 - "[Effectiveness of immunomodulating therapy of pulmonary tuberculosis with cycloferon]." 01/01/2012 - "[Cycloferon in the complex therapy of patients with widespread forms of pulmonary tuberculosis]." 01/01/2010 - "[Use of cycloferon in the treatment of patients with pulmonary tuberculosis with mild clinical manifestations]." 01/01/2012 - "A total of 238 patients, including 32 patients with limited forms of the pulmonary tuberculosis and 206 patients had widespread forms of pulmonary tuberculosis, were randomized into the basic group (BG) and comparison group (CG), where 95 CG patients received only polychemotherapy and 111 BG patients received polychemotherapy with the use of cycloferon. " 01/01/2015 - "We have evaluated the efficacy of cycloferon inclusion in the complex therapy of newly diagnosed patients with common forms of pulmonary tuberculosis, based on monitoring of the number of monocytes with receptors to interferon-gamma (flow cytometry) and the concentration of interferon-gamma in the serum (ELISA). "
5.	Chronic Hepatitis B 01/01/2010 - "[Cycloferon efficacy of therapy of chronic hepatitis B (results of randomized multicentre study)]." 11/01/2010 - "Therapy of chronic hepatitis B with cycloferon can reduce the frequency and severity of side effects, prevents the development of resistance to lamivudin and the emergence of mutant viruses." 11/01/2010 - "During treatment of patients with chronic hepatitis B the best therapeutic effect was obtained with the inclusion in the scheme of antiviral therapy cycloferon. " 01/01/2010 - "The best therapeutic effect in the treatment of patients with chronic hepatitis B was observed with the use of cycloferon in the scheme of the antiviral therapy. " 01/01/2013 - "There was observed a positive impact of the cycloferon therapy on the late aftereffects hepatitis C, evidemt from higher frequency of the remissions in the patients with chronic hepatitis B and less frequent transformation of the acute form to the chronic one. "

Related Drugs and Biologics

1.	Interferons
2.	Tablets
3.	Ribavirin (Virazole)
4.	Acyclovir (Aciclovir)
5.	Reamberin
6.	Meglumine
7.	Cytokines
8.	Interferon-gamma (Interferon, gamma)
9.	Hepatitis B Surface Antigens (HBsAg)
10.	Hepatitis B e Antigens

Related Therapies and Procedures

1.	Injections
2.	Drug Therapy (Chemotherapy)
3.	Immunotherapy
4.	Transplantation (Transplant Recipients)
5.	Radiotherapy